◆ [更新日:2020/07/02(木) 14:39:02]
■Lawyer gridlock expected for coming icac probes and other high-technology satellites due to FAA's inaction
"The Obama Administration is attempting to use its authority under FAA Modernization and Reform Act (FARPA) to enact and enforce a significant delay to the launch of new military communications satellites from a low-Earth orbit position where these satellites are likely to be deployed," said Sen. Richard Blumenthal.
The lawmakers said they are concerned that the delays will further hamper future commercial communications missions to the United States.
"FAA's decision to delay launches from low-Earth orbit was not based on anything other than this very specific threat, however," Blumenthal said. "By the end of the Obama Administration's second term, the commercial satellite launch industry will lose thousands of satellites every year and be impacted by the impact on commercial business operations.
"That does not come without consequences and it makes it imperative that this Administration, while ensuring that there is an effective and fair process for its decisions, also takes measures to ensure that the final decision on future commercial satellite launches follows in accordance with the law and our national interest," Blumenthal added. "By all means we should be able to monitor these systems and ensure that any actions of the Administration have an objective and good-faith basis."
This is not the first time Congress has used the FAA Modernization Act to delay the launch of new satellites. In a 2009 vote, for example, the Senate passed an exemption to the current satellite launch requirement. The measure would have made NASA the first commercial provider of launch services to customers using their own space vehicles and the first to be exempted from all launches requiring an international launch license.
Read the original story on Space.com.
<a href=https://wooriwin.com/>바카라사이트</a>
<a href=https://www.gohappyclub.com/>바카라</a>
<a href=https://www.cashmudra.com/>온라인카지노</a>
<a href=https://www.forexlingo.com/>예스카지노</a>
<a href=https://www.webix3.com/>카지노사이트</a>
Hospital rejects surgeons group claims of death penalty violations
Hospital refuses to release details of patient in death of Texas patient
The Texas medical board has refused to release details of what happened when Michael J. Miller was treated for acute myeloid leukaemia, a blood cancer, at a hospital in Corpus Christi. Miller died last November, and Texas medical officials charged with investigating his death say it was an attempt to cover-up misconduct at the hospital.
The chief of staff of the Texas Medical Board's hospital ethics unit testified Tuesday that his office refused to release details of Miller's medical care because a federal patient privacy law prevented it. In his statement, Lee B. Harris acknowledged "that I did not have the authority" to release any information, including the patients who saw Miller over the weekend when he was admitted.
Harris said that Texas Department of State Health Services hospitals would not cooperate with his inquiry into Miller's treatment by Houston Methodist Hospital, a separate entity from the state medical board. That hospital has since fired a hospital representative who investigated. Texas law bars hospitals from commenting on matters that are before the medical board, according to state records.
Houston Methodist denied that its hospital's investigation was biased.
"We look forward to the board's complete accounting of all of the facts surrounding this issue," said hospital spokeswoman Melissa Kappes. "If we were being asked to conduct an investigation we would do so. We believe that such a decision would impact both the health and well-being of our patients."
Miller had been a Dallas-area resident with a condition linked to his blood — a blood type known as type-1 diabetes — since March. He had previously gotten a partial blood test that showed mild signs of diabetes; but his condition worsened, including his blood sugar rose to nearly 100 percent, according to state records. Miller also took prescription drugs for his condition, but authorities suspected them of causing the severe kidney failure that led to his death last November.
Miller's family sought $1 million from the medical board to settle a class action lawsuit that alleged that Houston Methodist misled him about his conditions and gave false or misleading information about Miller's treatment.
Miller had become the focus of a probe into whether he should have been charged with criminal homicide in the death of a patient at a separate hospital in May after an autopsy found that the man died of a "severe vascular event," and was not a drug overdose. But Harris refused to press charges against the Texas Medical Board, leaving the door open to any future actions against Harris, who took office the next day.
The Texas Medical Board declined to comment on the investigation.
Harris and his predecessor, Dr. Larry J. Gilden — also chief medical officer — have not been formall
https://www.shamsbim.com/
戻る